Article
Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium.
Frontiers in endocrinology - 1 Jan 2021
Laurent Michaël R, De Schepper Jean, Trouet Dominique, Godefroid Nathalie, Boros Emese, Heinrichs Claudine, Bravenboer Bert, Velkeniers Brigitte, Lammens Johan, Harvengt Pol, Cavalier Etienne, Kaux Jean-François, Lombet Jacques, De Waele Kathleen, Verroken Charlotte, van Hoeck Koenraad, Mortier Geert R, Levtchenko Elena, Vande Walle Johan
Abstract excerpt
X-linked hypophosphatemia (XLH) is the most common genetic form of hypophosphatemic rickets and osteomalacia. In this disease, mutations in the PHEX gene lead to elevated levels of the hormone fibroblast growth factor 23 (FGF23), resulting in renal phosphate wasting and impaired skeletal and dental mineralization. Recently, international guidelines for the diagnosis and treatment of this condition have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
